Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine

NCT05706324 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation

Sponsor

Wuhan BravoVax Co., Ltd.

Collaborators

[object Object]
[object Object]